Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Jaguar Animal Health ( (JAGX) ) is now available.
On March 5, 2026, Jaguar Health disclosed that it had received notice from Nasdaq that its common stock had closed below the $1.00 minimum bid price for 30 consecutive business days and that, due to its prior large reverse stock splits, it is not eligible for a standard compliance period. Nasdaq indicated the company’s securities would be scheduled for delisting unless it requests a hearing by March 12, 2026, prompting Jaguar Health to state that it plans to appeal, a step that would temporarily stay any suspension or delisting while the process runs its course.
The notification underscores heightened delisting risk for Jaguar Health and creates uncertainty for shareholders, as there is no assurance the hearings panel will allow the company to maintain its listing or that it can regain and sustain compliance with Nasdaq’s continued listing requirements. The situation may affect investor confidence and trading liquidity, given that a potential move off Nasdaq would typically reduce visibility in the public markets and could constrain the company’s financial flexibility.
The most recent analyst rating on (JAGX) stock is a Hold with a $0.65 price target. To see the full list of analyst forecasts on Jaguar Animal Health stock, see the JAGX Stock Forecast page.
Spark’s Take on JAGX Stock
According to Spark, TipRanks’ AI Analyst, JAGX is a Neutral.
The score is held down primarily by weak financial performance (large ongoing losses, high leverage, and heavy cash burn) and a bearish technical setup (trading below all major moving averages with negative MACD). Corporate events provide a meaningful positive offset via non-dilutive funding and encouraging clinical progress, but not enough to overcome current financial and trend risks.
To see Spark’s full report on JAGX stock, click here.
More about Jaguar Animal Health
Jaguar Health, Inc. is a pharmaceutical company listed on the Nasdaq Capital Market that develops and commercializes prescription medicines. Its business and regulatory profile is closely tied to U.S. securities listing standards, making ongoing compliance with Nasdaq rules important for access to public capital markets and liquidity for its common stock.
Average Trading Volume: 3,861,034
Technical Sentiment Signal: Sell
Current Market Cap: $2.25M
Find detailed analytics on JAGX stock on TipRanks’ Stock Analysis page.